308 related articles for article (PubMed ID: 32059544)
1. Endoglin: Beyond the Endothelium.
Schoonderwoerd MJA; Goumans MTH; Hawinkels LJAC
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059544
[No Abstract] [Full Text] [Related]
2. Structural Basis of the Human Endoglin-BMP9 Interaction: Insights into BMP Signaling and HHT1.
Saito T; Bokhove M; Croci R; Zamora-Caballero S; Han L; Letarte M; de Sanctis D; Jovine L
Cell Rep; 2017 May; 19(9):1917-1928. PubMed ID: 28564608
[TBL] [Abstract][Full Text] [Related]
3. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
4. Curtailing endothelial TGF-β signaling is sufficient to reduce endothelial-mesenchymal transition and fibrosis in CKD.
Xavier S; Vasko R; Matsumoto K; Zullo JA; Chen R; Maizel J; Chander PN; Goligorsky MS
J Am Soc Nephrol; 2015 Apr; 26(4):817-29. PubMed ID: 25535303
[TBL] [Abstract][Full Text] [Related]
5. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
[TBL] [Abstract][Full Text] [Related]
6. Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling.
Kumar S; Pan CC; Bloodworth JC; Nixon AB; Theuer C; Hoyt DG; Lee NY
Oncogene; 2014 Jul; 33(30):3970-9. PubMed ID: 24077288
[TBL] [Abstract][Full Text] [Related]
7. Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling.
Eleftheriou NM; Sjölund J; Bocci M; Cortez E; Lee SJ; Cunha SI; Pietras K
Oncotarget; 2016 Dec; 7(51):84314-84325. PubMed ID: 27741515
[TBL] [Abstract][Full Text] [Related]
8. Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains.
Kienast Y; Jucknischke U; Scheiblich S; Thier M; de Wouters M; Haas A; Lehmann C; Brand V; Bernicke D; Honold K; Lorenz S
J Biol Chem; 2016 Feb; 291(7):3395-410. PubMed ID: 26677222
[TBL] [Abstract][Full Text] [Related]
9. Endoglin Expression on Cancer-Associated Fibroblasts Regulates Invasion and Stimulates Colorectal Cancer Metastasis.
Paauwe M; Schoonderwoerd MJA; Helderman RFCP; Harryvan TJ; Groenewoud A; van Pelt GW; Bor R; Hemmer DM; Versteeg HH; Snaar-Jagalska BE; Theuer CP; Hardwick JCH; Sier CFM; Ten Dijke P; Hawinkels LJAC
Clin Cancer Res; 2018 Dec; 24(24):6331-6344. PubMed ID: 29945992
[TBL] [Abstract][Full Text] [Related]
10. Atheroprone fluid shear stress-regulated ALK1-Endoglin-SMAD signaling originates from early endosomes.
Mendez PL; Obendorf L; Jatzlau J; Burdzinski W; Reichenbach M; Nageswaran V; Haghikia A; Stangl V; Hiepen C; Knaus P
BMC Biol; 2022 Sep; 20(1):210. PubMed ID: 36171573
[TBL] [Abstract][Full Text] [Related]
11. Assignment of transforming growth factor beta1 and beta3 and a third new ligand to the type I receptor ALK-1.
Lux A; Attisano L; Marchuk DA
J Biol Chem; 1999 Apr; 274(15):9984-92. PubMed ID: 10187774
[TBL] [Abstract][Full Text] [Related]
12. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
Aykul S; Martinez-Hackert E
J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic action of tranexamic acid in hereditary haemorrhagic telangiectasia (HHT): regulation of ALK-1/endoglin pathway in endothelial cells.
Fernandez-L A; Garrido-Martin EM; Sanz-Rodriguez F; Ramirez JR; Morales-Angulo C; Zarrabeitia R; Perez-Molino A; Bernabéu C; Botella LM
Thromb Haemost; 2007 Feb; 97(2):254-62. PubMed ID: 17264955
[TBL] [Abstract][Full Text] [Related]
14. Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.
Pece-Barbara N; Vera S; Kathirkamathamby K; Liebner S; Di Guglielmo GM; Dejana E; Wrana JL; Letarte M
J Biol Chem; 2005 Jul; 280(30):27800-8. PubMed ID: 15923183
[TBL] [Abstract][Full Text] [Related]
15. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
Barbara NP; Wrana JL; Letarte M
J Biol Chem; 1999 Jan; 274(2):584-94. PubMed ID: 9872992
[TBL] [Abstract][Full Text] [Related]
16. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis.
van den Driesche S; Mummery CL; Westermann CJ
Cardiovasc Res; 2003 Apr; 58(1):20-31. PubMed ID: 12667943
[TBL] [Abstract][Full Text] [Related]
17. Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.
Fernández-L A; Sanz-Rodriguez F; Blanco FJ; Bernabéu C; Botella LM
Clin Med Res; 2006 Mar; 4(1):66-78. PubMed ID: 16595794
[TBL] [Abstract][Full Text] [Related]
18. Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis.
Redgrave RE; Tual-Chalot S; Davison BJ; Singh E; Hall D; Amirrasouli MM; Gilchrist D; Medvinsky A; Arthur HM
Stem Cell Reports; 2017 May; 8(5):1287-1298. PubMed ID: 28494939
[TBL] [Abstract][Full Text] [Related]
19. Endoglin in human liver disease and murine models of liver fibrosis-A protective factor against liver fibrosis.
Alsamman M; Sterzer V; Meurer SK; Sahin H; Schaeper U; Kuscuoglu D; Strnad P; Weiskirchen R; Trautwein C; Scholten D
Liver Int; 2018 May; 38(5):858-867. PubMed ID: 28941022
[TBL] [Abstract][Full Text] [Related]
20. Endoglin: An 'Accessory' Receptor Regulating Blood Cell Development and Inflammation.
Meurer SK; Weiskirchen R
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]